PRVA250117P20000
- 1.15
- 0.000.00%
Privia Health Newsroom
Needham Initiates Coverage On Privia Health Gr With Buy Rating, Announces Price Target of $25
Express News | Privia Health Group Inc : Needham Initiates Coverage With Buy Rating; Target Price $25
RBC Capital Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $28
RBC Capital Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts
Macquarie Initiates Privia Health(PRVA.US) With Buy Rating, Announces Target Price $25
Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m
Privia Health Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $28
Express News | Privia Health Group Inc : Jefferies Raises Target Price to $26 From $25
Buy-rated Stocks With Passive and Active Net Buying Tailwinds – Citi
We Think You Can Look Beyond Privia Health Group's (NASDAQ:PRVA) Lackluster Earnings
Privia Health Group: Strong Performance and Growth Potential Justifies Buy Rating
Stifel Nicolaus Sticks to Its Buy Rating for Privia Health Group (PRVA)
A Quick Look at Today's Ratings for Privia Health(PRVA.US), With a Forecast Between $25 to $29
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript Summary
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript